Hovione
Hovione is a Contract Development and Manufacturing Organization with over 60 years of experience, dedicated to helping pharmaceutical customers bring new and off-patent drugs to market. The company emphasizes innovation, quality, and dependability, with a culture rooted in values such as integrity, teamwork, and customer focus. It operates globally with multiple FDA-inspected sites and development laboratories, offering comprehensive services across the entire drug lifecycle, including specialized capabilities in inhalation, particle engineering, and formulation development. Hovione is recognized as a top employer, committed to sustainability, ethical practices, and advancing pharmaceutical technologies.
Industries
Nr. of Employees
Very Large (1000+)
Hovione
Rua de Oeiras, 415, 2770-465 Paço de Arcos, Portugal
Products
Off-patent API portfolio
A portfolio of niche generic active pharmaceutical ingredients manufactured under cGMP with emphasis on chemical purity and consistent supply for finished dosage customers.
Compact dry-powder inhaler device format
Low-complexity dry-powder inhaler format designed for compatibility with dry powder formulations and capsule-filling workflows.
High-throughput ASD spray-drying screening platform
Small-material screening methodology to identify scalable amorphous solid dispersion formulations for poorly water-soluble candidates with rapid turnaround and low API consumption.
Off-patent API portfolio
A portfolio of niche generic active pharmaceutical ingredients manufactured under cGMP with emphasis on chemical purity and consistent supply for finished dosage customers.
Compact dry-powder inhaler device format
Low-complexity dry-powder inhaler format designed for compatibility with dry powder formulations and capsule-filling workflows.
High-throughput ASD spray-drying screening platform
Small-material screening methodology to identify scalable amorphous solid dispersion formulations for poorly water-soluble candidates with rapid turnaround and low API consumption.
Services
Integrated development and manufacturing services for drug substances, intermediates and finished products spanning R&D, scale-up and commercial supply under cGMP.
Laboratory analytical testing, stability studies and PAT method support to measure critical quality attributes during development and for GMP release testing.
Quality system implementation, audit readiness, and regulatory affairs support for product development and manufacturing operations.
Continuity planning, supplier relationship management and contingency procedures to mitigate supply chain risk for regulated manufacturing.
Development of aqueous micellar process routes for chemical transformations in API synthesis to reduce organic solvent use and lower process environmental impact.
Licensing, joint-venture and formulation services to develop and commercialize solubility/bioavailability enhancement platforms across delivery routes, including excipient sourcing coordination.
Integrated development and manufacturing services for drug substances, intermediates and finished products spanning R&D, scale-up and commercial supply under cGMP.
Laboratory analytical testing, stability studies and PAT method support to measure critical quality attributes during development and for GMP release testing.
Quality system implementation, audit readiness, and regulatory affairs support for product development and manufacturing operations.
Continuity planning, supplier relationship management and contingency procedures to mitigate supply chain risk for regulated manufacturing.
Development of aqueous micellar process routes for chemical transformations in API synthesis to reduce organic solvent use and lower process environmental impact.
Licensing, joint-venture and formulation services to develop and commercialize solubility/bioavailability enhancement platforms across delivery routes, including excipient sourcing coordination.
Expertise Areas
- Particle engineering for oral, nasal and inhalation delivery
- Spray drying and spray‑freeze drying process development
- Scale-representative laboratory spray-drying and process simulation
- Continuous manufacturing and continuous tableting
Key Technologies
- Spray drying
- Scale-representative lab spray dryer and simulation tooling
- Spray‑freeze drying
- High-throughput ASD screening
News & Updates
Hovione and Firstgene collaborate to develop targeted gene therapy for Hepatocellular Carcinoma using virus-like particles.
Hovione informed clients about a power outage affecting its Portuguese sites, which lasted approximately 11 hours.
Hovione's new campus in Seixal, Portugal, is in the final construction phase, supporting future expansion and technological advancement.
Hovione's strategic collaborations and technological expertise address complex pharmaceutical challenges, including drug delivery and bioavailability.
Hovione is recognized as a leader in inhalation drug development, supporting the growing market with advanced technologies.
Hovione emphasizes the importance of continuous manufacturing technologies in accelerating drug development and ensuring quality.
Hovione and Firstgene collaborate to develop targeted gene therapy for Hepatocellular Carcinoma using virus-like particles.
Hovione informed clients about a power outage affecting its Portuguese sites, which lasted approximately 11 hours.
Hovione's new campus in Seixal, Portugal, is in the final construction phase, supporting future expansion and technological advancement.
Hovione's strategic collaborations and technological expertise address complex pharmaceutical challenges, including drug delivery and bioavailability.
Hovione is recognized as a leader in inhalation drug development, supporting the growing market with advanced technologies.
Hovione emphasizes the importance of continuous manufacturing technologies in accelerating drug development and ensuring quality.